Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
regulatory approvals
Biotech
Moderna posts come-from-behind RSV data
A top-line readout from COVID-19 vaccine maker Moderna for a respiratory syncytial virus vaccine seems to keep pace with leading competitors.
Max Bayer
Jan 17, 2023 4:55pm
Agenus withdraws cervical cancer application for balstilimab
Oct 22, 2021 8:00am
FDA stands by Aduhelm approval, use of accelerated pathway
Jul 13, 2021 3:33pm
Boston Scientific’s radioactive implant extends cancer survival
Mar 29, 2021 11:58am
Fauci: FDA will make its own decisions about COVID-19 vaccines
Aug 7, 2020 5:15am
BIO explores COVID-19's opportunities for big data, new regs
Jun 10, 2020 9:10am